These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21625573)

  • 1. A multiscale approach to characterize the early aggregation steps of the amyloid-forming peptide GNNQQNY from the yeast prion sup-35.
    Nasica-Labouze J; Meli M; Derreumaux P; Colombo G; Mousseau N
    PLoS Comput Biol; 2011 May; 7(5):e1002051. PubMed ID: 21625573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35.
    Zheng J; Ma B; Tsai CJ; Nussinov R
    Biophys J; 2006 Aug; 91(3):824-33. PubMed ID: 16679374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic analysis of structural transitions during GNNQQNY aggregation.
    Osborne KL; Bachmann M; Strodel B
    Proteins; 2013 Jul; 81(7):1141-55. PubMed ID: 23408546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.
    Qi X; Hong L; Zhang Y
    Biophys J; 2012 Feb; 102(3):597-605. PubMed ID: 22325283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of sequence, topology and termini charge in determining the stability of the aggregates of GNNQQNY mutants: a molecular dynamics study.
    Srivastava A; Balaji PV
    PLoS One; 2014; 9(5):e96660. PubMed ID: 24817093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRMAS 1H NMR conformational study of the resin-bound amyloid-forming peptide GNNQQNY from the yeast prion Sup35.
    Andrey SB; Chan ML; Power WP
    J Phys Chem A; 2010 Mar; 114(10):3457-65. PubMed ID: 20155963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
    Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
    Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations on the oligomer-formation process of the GNNQQNY peptide from yeast prion protein Sup35.
    Zhang Z; Chen H; Bai H; Lai L
    Biophys J; 2007 Sep; 93(5):1484-92. PubMed ID: 17483185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Top-down Multiscale Approach To Simulate Peptide Self-Assembly from Monomers.
    Zhao X; Liao C; Ma YT; Ferrell JB; Schneebeli ST; Li J
    J Chem Theory Comput; 2019 Mar; 15(3):1514-1522. PubMed ID: 30677300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering and Fibril Formation during GNNQQNY Aggregation: A Molecular Dynamics Study.
    Szała-Mendyk B; Molski A
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy.
    Langkilde AE; Morris KL; Serpell LC; Svergun DI; Vestergaard B
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):882-95. PubMed ID: 25849399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the assembly of the Sup35 yeast prion fragment, GNNQQNY: structural changes accompany a fiber-to-crystal switch.
    Marshall KE; Hicks MR; Williams TL; Hoffmann SV; Rodger A; Dafforn TR; Serpell LC
    Biophys J; 2010 Jan; 98(2):330-8. PubMed ID: 20338855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35.
    Gsponer J; Haberthür U; Caflisch A
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5154-9. PubMed ID: 12700355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer.
    Berhanu WM; Masunov AE
    Biophys Chem; 2010 Jun; 149(1-2):12-21. PubMed ID: 20456856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of amyloid aggregation: a study of the GNNQQNY prion sequence.
    Nasica-Labouze J; Mousseau N
    PLoS Comput Biol; 2012; 8(11):e1002782. PubMed ID: 23209391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct amino acid compositional requirements for formation and maintenance of the [PSI⁺] prion in yeast.
    MacLea KS; Paul KR; Ben-Musa Z; Waechter A; Shattuck JE; Gruca M; Ross ED
    Mol Cell Biol; 2015 Mar; 35(5):899-911. PubMed ID: 25547291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of hydration and confinement in the aggregation of amyloidogenic peptides Aβ(16-22) and Sup35(7-13) in AOT reverse micelles.
    Martinez AV; Małolepsza E; Rivera E; Lu Q; Straub JE
    J Chem Phys; 2014 Dec; 141(22):22D530. PubMed ID: 25494801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism and application of molecular self-assembly in Sup35 prion domain of Saccharomyces cerevisiae].
    Yin W; He J; Yu Z; Wang J
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1401-7. PubMed ID: 22260056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events during the early stages of aggregation of GNNQQNY: An all atom MD simulation study of randomly dispersed peptides.
    Srivastava A; Balaji PV
    J Struct Biol; 2015 Dec; 192(3):376-391. PubMed ID: 26433030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.